<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02432794</url>
  </required_header>
  <id_info>
    <org_study_id>APIL_2013</org_study_id>
    <nct_id>NCT02432794</nct_id>
  </id_info>
  <brief_title>Trial on Delay Phenomenon Utility in Preventing Anastomotic Leakage After an Esophagectomy</brief_title>
  <acronym>APIL_2013</acronym>
  <official_title>A Prospective Randomized Clinical Trial on Delay Phenomenon Utility in Preventing Oesophagogastric Anastomotic Dehiscence After an Ivor-Lewis Esophagectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari de Bellvitge</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari de Bellvitge</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized clinical trial to clarify if the delay phenomenon could reduce the
      incidence of oesophagogastric dehiscence after an esophagectomy for esophageal cancer
      comparing an experimental group vs control group. The delay phenomenon will be performed by
      an arteriographic approach.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subtotal esophagectomy with tubular gastroplasty to upper mediastinum and esophagogastric
      anastomosis (Ivor-Lewis procedure) is a very complex surgical technique. It is performed in
      patients with infracarinal esophageal carcinoma and is associated with a high morbidity rate
      in specialized centers (up to 60% in some groups). One of the most important postoperative
      complications is the oesophagogastric anastomotic leakage which leads a high morbidity
      (mediastinitis, respiratory failure, pleural effusion) and mortality rate (up to 60%
      depending on the reports).

      The most important cause of anastomotic leakage is the stomach's extreme sensitivity to
      ischemic injury. There are several experimental studies that have demonstrated that the delay
      phenomenon before the esophageal resection surgery aims to improve issue perfusion after a
      period of time. Few studies, only cases reports, describe a decrease of the incidence of
      intrathoracic and cervical anastomotic leakage. May the delay phenomenon reduce the incidence
      of anastomotic intrathoracic leakage?. There aren't prospective randomized controlled trials
      to answer this question.

      For this reason the investigators propose to perform a prospective randomized controlled
      trial in patients underwent on a subtotal esophagectomy (Ivor-Lewis procedure), comparing two
      groups: one of them will be subjected a delay phenomenon by arteriographic procedure before
      esophageal resection surgery, and the other one will be operated directly, to demonstrate if
      the delay phenomenon can reduce the incidence of anastomotic esophagogastric leakage.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anastomotic leakage</measure>
    <time_frame>7 days</time_frame>
    <description>investigators will consider anastomotic dehiscence the presence of one or more of the following conditions: radiologic confirmation by water-soluble contrast study (gastrografin administered orally) or thoracoabdominal Tc with oral contrast of dehiscence of oesophagogastric anastomosis or the stapler end of the gastroplasty.
When the clinical conditions of patient don't allow a Rx control investigators will consider an anastomotic leakage in these conditions:
Thoracic drain output of oesophagogastric content with amylase &gt; 40 ukAT/L, confirmation of anastomotic dehiscence by the surgeon during a reintervention, endoscopic confirmation of anastomotic leakage of the stapled end of the plasty and methylene blue output after oral administration (100 ml of water with 10ml of methylene blue)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>plasty ischemia</measure>
    <time_frame>7 days</time_frame>
    <description>investigators will consider plasty ischemia when one or more of the following criteria is present:
endoscopic evidence of gastric mucosa ischemia
evidence of low captation of the plasty in a thoracoabdominal CT with endovenous contrast that requires a reintervention.
intraoperative mortality (during hospitalization and/or 30 days after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital stay</measure>
    <time_frame>90 days</time_frame>
    <description>investigators will consider since the day of the surgery until the day the patient will be discharged from the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>major and minor morbidity</measure>
    <time_frame>90 days</time_frame>
    <description>investigators will evaluate morbidity according to Clavien-Dindo classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative mortality</measure>
    <time_frame>during hospitalization and/or 30 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-embolization morbidity</measure>
    <time_frame>30 days</time_frame>
    <description>investigators will consider post-embolization morbidity the following situations:
abdominal pain with EVA&gt;3 (evaluated by EVA classification )
pancreatitis diagnosed by abdominal pain and amylase &gt; 5 uKat/L or by CT.
abscess, pseudocyst diagnosed by CT or during oesophageal surgery
spleen ischemia diagnosed by CT or abdominal ultrasound and needs some treatment
liver ischemia diagnosed by Ct or abdominal ultrasound
bleeding or artery dissection diagnosed during the embolization and needs some treatment
arterial pseudoaneurism diagnosed during the embolization or by CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anastomotic stricture</measure>
    <time_frame>6 months</time_frame>
    <description>investigators will consider anastomotic stricture when they observe a reduction of anastomotic diameter by oral contrast Rx and needs some treatment (endoscopic dilation or reintervention)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Esophageal Anastomotic Leak</condition>
  <arm_group>
    <arm_group_label>delay phenomenon by arteriography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intervention: delay phenomenon by arteriography. Patients who will be subjected a delay phenomenon by arteriographic procedure before esophageal resection surgery minimum 14 days before surgery.
An angiogram of the celiac trunk is performed through a femoral access before and after the embolization. A 4-5 Fr Simmons or Cobra catheter is used for the catheterization and embolization of the left gastric artery, and 0.035-inch platinum coils are proximally placed from the main trunk in the splenic artery. When accessory left gastric arteries are present, they are catheterized and embolized as well. The right gastric artery catheterization is realized by a 4-5 Fr catheter and coils or microcoils are proximally placed in the artery as well.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients who will be operated directly without gastric ischemic conditioning. The investigators don't performed any arteriography before the esophageal surgical resection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>delay phenomenon by arteriographic approach</intervention_name>
    <description>we improve the microvascularization of the gastric fundus occluding the right and left gastric artery, and splenic artery two weeks before surgery by arteriography</description>
    <arm_group_label>delay phenomenon by arteriography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients requiring a subtotal esophagectomy with en-bloc resection and an
             intrathoracic esophagogastrostomy for esophageal cancer

          -  18 or above years old

          -  Acceptance and signing the full informed consent

        Exclusion Criteria:

          -  Absence of pancreatitis

          -  Anatomic vascular alteration that contraindicate the embolization (congenital celiac
             trunk stenosis, presence of arcuate ligament,etc,..)

          -  refuse to collaborate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leandre F Teixidor, Ph D, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bellvitge University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leandre F Teixidor, Ph D, MD</last_name>
    <phone>+34-93-335-90-11</phone>
    <phone_ext>2316</phone_ext>
    <email>lfarran@bellvitgehospital.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mònica M Martín, Ph D, MD</last_name>
    <phone>+34-93-335-90-11</phone>
    <phone_ext>2316</phone_ext>
    <email>mmiro@bellvitgehospital.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Leandre Farran Teixidor</name>
      <address>
        <city>l'Hospitalet del Llobregat</city>
        <state>Barcelona</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leandre F teixidor, Ph D, MD</last_name>
      <phone>+34-93-335-90-11</phone>
      <phone_ext>2316</phone_ext>
      <email>lfarran@bellvitgehospital.cat</email>
    </contact>
    <contact_backup>
      <last_name>Mònica M Martín, Ph D, MD</last_name>
      <phone>+34-93-335-90-11</phone>
      <phone_ext>2316</phone_ext>
      <email>mmiro@bellvitgehospital.cat</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>González-González JJ, Sanz-Alvarez L, Marqués-Alvarez L, Navarrete-Guijosa F, Martínez-Rodríguez E. [Complications of surgical resection of esophageal cancer]. Cir Esp. 2006 Dec;80(6):349-60. Review. Spanish.</citation>
    <PMID>17192218</PMID>
  </results_reference>
  <results_reference>
    <citation>Schröder W, Beckurts KT, Stähler D, Stützer H, Fischer JH, Hölscher AH. Microcirculatory changes associated with gastric tube formation in the pig. Eur Surg Res. 2002 Nov-Dec;34(6):411-7.</citation>
    <PMID>12403940</PMID>
  </results_reference>
  <results_reference>
    <citation>Farran Teixidor L, Llop Talaverón J, Galán Guzmán M, Aranda Danso H, Miró Martín M, Bettónica Larrañaga C, Estremiana García F, Biondo S. [Surgical outcomes of esophageal cancer resection since the development of an Oesophagogastric Tumour Board]. Cir Esp. 2013 Oct;91(8):517-23. doi: 10.1016/j.ciresp.2012.12.005. Epub 2013 Apr 11. Spanish.</citation>
    <PMID>23583091</PMID>
  </results_reference>
  <results_reference>
    <citation>Patil PK, Patel SG, Mistry RC, Deshpande RK, Desai PB. Cancer of the esophagus: esophagogastric anastomotic leak--a retrospective study of predisposing factors. J Surg Oncol. 1992 Mar;49(3):163-7.</citation>
    <PMID>1548890</PMID>
  </results_reference>
  <results_reference>
    <citation>Griffin SM, Shaw IH, Dresner SM. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management. J Am Coll Surg. 2002 Mar;194(3):285-97.</citation>
    <PMID>11893132</PMID>
  </results_reference>
  <results_reference>
    <citation>Schröder W, Hölscher AH, Bludau M, Vallböhmer D, Bollschweiler E, Gutschow C. Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World J Surg. 2010 Apr;34(4):738-43. doi: 10.1007/s00268-010-0403-x.</citation>
    <PMID>20098986</PMID>
  </results_reference>
  <results_reference>
    <citation>Metzger R, Bollschweiler E, Vallböhmer D, Maish M, DeMeester TR, Hölscher AH. High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus. 2004;17(4):310-4. Review.</citation>
    <PMID>15569369</PMID>
  </results_reference>
  <results_reference>
    <citation>Liebermann-Meffert DM, Meier R, Siewert JR. Vascular anatomy of the gastric tube used for esophageal reconstruction. Ann Thorac Surg. 1992 Dec;54(6):1110-5.</citation>
    <PMID>1449294</PMID>
  </results_reference>
  <results_reference>
    <citation>Boyle NH, Pearce A, Hunter D, Owen WJ, Mason RC. Scanning laser Doppler flowmetry and intraluminal recirculating gas tonometry in the assessment of gastric and jejunal perfusion during oesophageal resection. Br J Surg. 1998 Oct;85(10):1407-11.</citation>
    <PMID>9782026</PMID>
  </results_reference>
  <results_reference>
    <citation>Urschel JD. Ischemic conditioning of the rat stomach: implications for esophageal replacement with stomach. J Cardiovasc Surg (Torino). 1995 Apr;36(2):191-3.</citation>
    <PMID>7790342</PMID>
  </results_reference>
  <results_reference>
    <citation>Yuan Y, Duranceau A, Ferraro P, Martin J, Liberman M. Vascular conditioning of the stomach before esophageal reconstruction by gastric interposition. Dis Esophagus. 2012 Nov-Dec;25(8):740-9. doi: 10.1111/j.1442-2050.2011.01311.x. Epub 2012 Jan 31. Review.</citation>
    <PMID>22292613</PMID>
  </results_reference>
  <results_reference>
    <citation>Akiyama S, Kodera Y, Sekiguchi H, Kasai Y, Kondo K, Ito K, Takagi H. Preoperative embolization therapy for esophageal operation. J Surg Oncol. 1998 Dec;69(4):219-23.</citation>
    <PMID>9881938</PMID>
  </results_reference>
  <results_reference>
    <citation>Isomura T, Itoh S, Endo T, Akiyama S, Maruyama K, Ishiguchi T, Ishigaki T, Takagi H. Efficacy of gastric blood supply redistribution by transarterial embolization: preoperative procedure to prevent postoperative anastomotic leaks following esophagoplasty for esophageal carcinoma. Cardiovasc Intervent Radiol. 1999 Mar-Apr;22(2):119-23.</citation>
    <PMID>10094991</PMID>
  </results_reference>
  <results_reference>
    <citation>Lamas S, Azuara D, de Oca J, Sans M, Farran L, Alba E, Escalante E, Rafecas A. Time course of necrosis/apoptosis and neovascularization during experimental gastric conditioning. Dis Esophagus. 2008;21(4):370-6. doi: 10.1111/j.1442-2050.2007.00772.x.</citation>
    <PMID>18477261</PMID>
  </results_reference>
  <results_reference>
    <citation>Farran L, Miro M, Alba E, Bettonica C, Aranda H, Galan M, Rafecas A. Preoperative gastric conditioning in cervical gastroplasty. Dis Esophagus. 2011 May;24(4):205-10. doi: 10.1111/j.1442-2050.2010.01115.x. Epub 2010 Oct 11.</citation>
    <PMID>21040153</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2015</study_first_submitted>
  <study_first_submitted_qc>May 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2015</study_first_posted>
  <last_update_submitted>August 26, 2017</last_update_submitted>
  <last_update_submitted_qc>August 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitari de Bellvitge</investigator_affiliation>
    <investigator_full_name>Leandre Farran Teixidor</investigator_full_name>
    <investigator_title>Chief of oesophagogastric surgery department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anastomotic Leak</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

